Kenvue (KVUE) Stock Forecast & Price Target
$37.31B
Market Cap
22.22
P/E
16.52
Forward P/E
49
Score
KVUE price $19.43 +0.10 +0.49%
Stocklytics score rationale: value 53, quality 58, growth 35.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 14324000000 | 14467000000 | 15054000000 | 14950000000 | 15444000000 | 15455000000 | 15124000000 |
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent…
Consensus Hold from 14 analysts. Average price target $19.50, +0.4% versus the current price. Low $19.00. High $20.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $19.50 for Kenvue (KVUE), 0.4% above the current price of $19.43. Of 14 analysts covering the stock, 2 rate it Buy or Strong Buy, 12 Hold, and 0 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $19.00 |
|---|---|
| Average | $19.50 |
| High | $20.00 |
The average is 0.4% above the current price of $19.43.
Of 14 analysts, 2 rate Kenvue Buy or Strong Buy, 12 Hold, and 0 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
Analyst averages on file: 2026, EPS $1.18, revenue $15.61 billion. 2027, EPS $1.25, revenue $15.97 billion.
The Stocklytics Score for KVUE is 49 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$19.50 average, with a published range of $19.00 to $20.00.
The consensus is Hold from 14 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $1.18. The average revenue estimate is $15.61 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Kenvue · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$37.31B
Market Cap
22.22
P/E
16.52
Forward P/E
49
Score